Company Monitoring Page for MannKind

latest headlines for company on cafepharma

Here's Why MannKind Corporation Remained Stuck in Reverse and Lost 24% in February
Motley Fool
Sun, 03/12/17 - 10:51 am
Tags:
MannKind, diabetes, inhaled insulin, Afrezza
Can MannKind Be Saved?
Barron's
Tue, 02/28/17 - 11:25 am
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
MannKind Attempts to Revive Afrezza Sales
Investopedia
Fri, 02/3/17 - 11:21 am
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
Afrezza Sales Still Low As MannKind Prepares For Investor Update
Seeking Alpha
Sat, 01/28/17 - 02:32 pm
Tags:
Afrezza, MannKind, diabetes, inhaled insulin
MannKind: Afrezza Sales Start Off 2017 Modestly. Will A Bigger Sales Force Make A Material Difference?
Seeking Alpha
Tue, 01/17/17 - 10:22 pm
Tags:
MannKind, Afrezza, diabetes, drug reps, inhaled insulin
JPM: Day 4 round-up
BioPharma Dive
Fri, 01/13/17 - 12:09 pm
Tags:
JPMHC 2017, Novavax, Tesaro, MannKind
MannKind's $1M Milestone: Good News, But Barely
Seeking Alpha
Wed, 01/4/17 - 10:41 am
Tags:
MannKind, diabetes, Receptor Life Sciences
MannKind Receives $1 Million Milestone From RLS
Yahoo
Tue, 01/3/17 - 09:50 am
Tags:
MannKind, Receptor Life Sciences
Mannkind's Afrezza Is Fizzling Out
Seeking Alpha
Mon, 01/2/17 - 11:55 am
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
2 Key Reasons MannKind Needs To Remain On Nasdaq
Seeking Alpha
Wed, 11/30/16 - 09:57 am
Tags:
MannKind, diabetes, NASDAQ, Afrezza
MannKind - Afrezza Scripts Still Low As Year-End Holidays Approach
Seeking Alpha
Mon, 11/28/16 - 11:40 pm
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
MannKind's Afrezza Sales Remain Below 300 Scripts - Can The Company Increase Sales Soon?
Seeking Alpha
Tue, 11/22/16 - 11:23 am
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
Sanofi Took $100M Hit on MannKind Deal
Investopedia
Sat, 11/12/16 - 04:35 pm
Tags:
Sanofi, MannKind, Afrezza, diabetes, inhaled insulin
MannKind, Sanofi Reach Agreement on AFREZZA; Sanofi to Purchase $10.2M Worth of Insulin from MannKind
Yahoo/Benzinga
Thu, 11/10/16 - 12:28 pm
Tags:
MannKind, Sanofi, Afrezza, inhaled insulin, diabetes
MannKind: Afrezza Sales Fizzle Going Into Quarterly Call
Seeking Alpha
Sat, 11/5/16 - 02:08 pm
Tags:
MannKind, Afrezza, diabetes, inhaled insulin, earnings
These 2 Biotechs Could Vanish by 2018
Motley Fool
Fri, 10/7/16 - 08:57 am
Tags:
biotech, Acadia, MannKind, Nuplazid, Afrezza
Can MannKind Compete Against Mylan's EpiPen?
Investopedia
Tue, 09/27/16 - 09:57 am
Tags:
MannKind, Mylan, EpiPen
MannKind - Take A Deep Breath, Afrezza Sales Numbers Are Tough To Swallow
Seeking Alpha
Tue, 09/20/16 - 08:36 pm
Tags:
MannKind, Afrezza, inhaled insulin, diabetes
Mylan may get the 'horns' from EpiPen competitors as pricing controversy burns hot
Fierce Pharma
Tue, 09/6/16 - 12:43 pm
Tags:
Mylan Labs, EpiPen, drug pricing, Teva Pharmaceutical, Impax Labs, MannKind
MannKind - 2 Months Into Relaunch Of Afrezza - Where Things Stand And What To Expect
Seeking Alpha
Fri, 09/2/16 - 10:26 pm
Tags:
MannKind, Afrezza, diabetes, drug launches

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.